The case for low carbohydrate diets in diabetes management

Division of Endocrinology, Diabetes and Hypertension, SUNY Downstate Medical Center, Kings County Hospital Center, Brooklyn, NY 11203, USA.
Nutrition & Metabolism (Impact Factor: 3.36). 07/2005; 2:16. DOI: 10.1186/1743-7075-2-16
Source: PubMed

ABSTRACT A low fat, high carbohydrate diet in combination with regular exercise is the traditional recommendation for treating diabetes. Compliance with these lifestyle modifications is less than satisfactory, however, and a high carbohydrate diet raises postprandial plasma glucose and insulin secretion, thereby increasing risk of CVD, hypertension, dyslipidemia, obesity and diabetes. Moreover, the current epidemic of diabetes and obesity has been, over the past three decades, accompanied by a significant decrease in fat consumption and an increase in carbohydrate consumption. This apparent failure of the traditional diet, from a public health point of view, indicates that alternative dietary approaches are needed. Because carbohydrate is the major secretagogue of insulin, some form of carbohydrate restriction is a prima facie candidate for dietary control of diabetes. Evidence from various randomized controlled trials in recent years has convinced us that such diets are safe and effective, at least in short-term. These data show low carbohydrate diets to be comparable or better than traditional low fat high carbohydrate diets for weight reduction, improvement in the dyslipidemia of diabetes and metabolic syndrome as well as control of blood pressure, postprandial glycemia and insulin secretion. Furthermore, the ability of low carbohydrate diets to reduce triglycerides and to increase HDL is of particular importance. Resistance to such strategies has been due, in part, to equating it with the popular Atkins diet. However, there are many variations and room for individual physician planning. Some form of low carbohydrate diet, in combination with exercise, is a viable option for patients with diabetes. However, the extreme reduction of carbohydrate of popular diets (<30 g/day) cannot be recommended for a diabetic population at this time without further study. On the other hand, the dire objections continually raised in the literature appear to have very little scientific basis. Whereas it is traditional to say that more work needs to be done, the same is true of the assumed standard low fat diets which have an ambiguous record at best. We see current trends in the national dietary recommendations as a positive sign and an appropriate move in the right direction.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: OBJECTIVE To compare weight change between clinical "Trial" and "Program" participants enrolled in a 24-week dietary counselling and supervised exercise program at a cardiac rehabilitation centre.METHODS For the period between January 2003 and December 2004, the following data were abstracted from clinic/trial charts: weight (baseline, 12 weeks, 24 weeks), age, sex, use of antihyperglycemic medication, glycated hemoglobin (A1C), fitness level and exercise class attendance. Weight change over 24 weeks, expressed as a percentage of baseline weight, was compared between groups in unadjusted and adjusted models.RESULTSTrial (n=18) and Program (n=18) participants were similar in terms of age, obesity, fitness and A1C. The proportion of women was somewhat lower in the Program group, and fewer Program participants reported the use of antihyperglycemic medication. Program participants attended a nonsignificantly higher number of exercise classes (45 vs. 39 sessions) and demonstrated significantly greater weight change (− 4.2% [SD 3.5] vs. -1.4% [SD 2.8], p=0.05) not explained by other measured variables.CONCLUSIONSWeight loss by Program participants suggests that a 24-week diet and exercise program may potentially achieve more weight loss than suggested by our original clinical trial. Possible reasons for between-group differences are discussed.RÉSUMÉOBJECTIFComparer le changement de poids entre les sujets d'un essai clinique et les participants à un programme de 24 semaines offert dans un centre de réadaptation cardiaque et comportant une thérapie nutritionnelle et un programme d'exercices supervisé.MÉTHODESDe janvier 2003 à décembre 2004 les données suivantes ont été extraites des dossiers des patients : poids (au départ et 12 et 24 semaines plus tard), âge, sexe, prise d'un antihyperglycémiant, hémoglobine glycosylée (HbA1c), condition physique et assiduité aux séances d'exercices. Le changement de poids au cours des 24 semaines, exprimé en pourcentage du poids initial, a été comparé entre les groupes dans des modèles rectifiés et non rectifiés.RÉSULTATSLes sujets de l'essai (n = 18) et les participants au programme (n = 18) étaient semblables en ce qui a trait à l'âge, l'obésité, la condition physique et l'HbA1c. Le programme comptait légèrement moins de femmes que l'essai clinique et un moins grand nombre de participants au programme que de sujets de l'essai ont signalé avoir pris un antihyperglycémiant. Les participants au programme ont assisté à un plus grand nombre de séances d'exercices (45 par rapport à 39, différence non significative) et leur poids a changé significativement plus que celui des sujets de l'essai clinique (− 4,2 % [ET : 3,5] par rapport à − 1,4 % [ET : 2,8], p = 0,05), ce qui n'a pu être attribué à aucune autre variable mesurée.CONCLUSIONS La perte de poids chez les participants au programme semble indiquer qu'un programme de 24 semaines comportant une thérapie nutritionnelle et des exercices pourrait réduire le poids davantage que notre essai clinique original le laissait supposer. Cet article traite des raisons possibles des différences entre les groupes.
    Canadian Journal of Diabetes 01/2008; 32(4):255–259. DOI:10.1016/S1499-2671(08)24005-0 · 0.46 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Obesity and diabetes are known risk factors for the development of physical disability among older adults. With the number of seniors with these conditions rising worldwide, the prevention and treatment of physical disability in these persons has become a major public health challenge. Sarcopenia, the progressive loss of muscle mass and strength, has been identified as a common pathway associated with the initial onset and progression of physical disability among older adults. A growing body of evidence suggests that metabolic dysregulation associated with obesity and diabetes accelerates the progression of sarcopenia, and subsequently functional decline in older adults. The focus of this brief review is on the contributions of obesity and diabetes in accelerating sarcopenia and functional decline among older adults. We also briefly discuss the underexplored interaction between obesity and diabetes that may further accelerate sarcopenia and place obese older adults with diabetes at particularly high risk of disability. Finally, we review findings from studies that have specifically tested the efficacy of lifestyle-based interventions in maintaining the functional status of older persons with obesity and/or diabetes.
    Experimental gerontology 07/2013; 48(9). DOI:10.1016/j.exger.2013.06.007 · 3.53 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Insulin resistance has been proposed as the strongest single predictor for the development of Type 2 Diabetes (T2DM). Chronic oversupply of energy from food, together with inadequate physical activity, have been recognized as the most relevant factors leading to overweight, abdominal adiposity, insulin resistance, and finally T2DM. Conversely, energy reduced diets almost invariably to facilitate weight loss and reduce abdominal fat mass and insulin resistance. However, sustained weight loss is generally difficult to achieve, and distinct metabolic characteristics in patients with T2DM further compromise success. Therefore, investigating the effects of modulating the macronutrient composition of isoenergetic diets is an interesting concept that may lead to additional important insights. Metabolic effects of various different dietary concepts and strategies have been claimed, but results from randomized controlled studies and particularly from longer-term-controlled interventions in humans are often lacking. However, some of these concepts are supported by recent research, at least in animal models and short-term studies in humans. This paper provides an update of the current literature regarding the role of nutrition in the modulation of insulin resistance, which includes the discussion of weight-loss-independent metabolic effects of commonly used dietary concepts.
    09/2012; 2012:424780. DOI:10.6064/2012/424780


Available from